June 20, 2024

Health Economics and Outcomes Research Services Market Size, Report By 2033

The global health economics and outcomes research (HEOR) services market size is expected to increase USD 4.63 billion by 2033 from USD 1.24 billion in 2023 with a CAGR of 14.05% between 2024 and 2033.

Key Points

  • North America led the market with the largest share in 2023.
  • By region, Asia Pacific is observed to experience a notable rate of growth during the forecast period.
  • By service, the market access solution and reimbursement segment dominated the health economics and outcomes research (HEOR) services market.
  • By service provider, the contract research organizations segment led the market in 2023.
  • By service provider, the consultancy segment is anticipated to grow at a notable rate in the market during the forecast period.
  • By end user, the pharma and biotech companies segment led the market in 2023.
  • By end user, the healthcare payers segment is observed to witness a significant growth rate during the forecast period.

Health Economics and Outcomes Research (HEOR) Services Market Size 2024 to 2033

The global market for Health Economics and Outcomes Research (HEOR) services is experiencing robust growth driven by the increasing emphasis on evidence-based healthcare decision-making. HEOR services play a critical role in evaluating the clinical and economic outcomes of healthcare interventions, drugs, and medical technologies. This market encompasses a range of services including health technology assessment (HTA), economic modeling, real-world evidence generation, and value dossiers. Key stakeholders such as pharmaceutical companies, healthcare providers, and policymakers rely on HEOR insights to optimize healthcare resource allocation and improve patient outcomes.

Get a Sample: https://www.precedenceresearch.com/sample/4238

Growth Factors

Several factors contribute to the growth of the HEOR services market. The rising demand for cost-effective healthcare solutions amid escalating healthcare costs is a primary driver. HEOR studies help assess the value of healthcare interventions in terms of patient outcomes relative to costs, aiding reimbursement decisions and market access strategies. Additionally, the growing adoption of value-based healthcare models and the increasing focus on patient-centered care are driving the need for robust HEOR evidence to support clinical and policy decisions.

Region Insights

The market for HEOR services exhibits regional variations influenced by healthcare policies, regulatory frameworks, and healthcare expenditure patterns. North America dominates the market, driven by strong investments in healthcare research and favorable reimbursement policies. Europe follows closely, characterized by extensive HTA activities and a well-established market for HEOR services. Emerging markets in Asia-Pacific, such as China and India, are witnessing rapid growth fueled by expanding healthcare infrastructure and increasing awareness of health economics.

Health Economics and Outcomes Research (HEOR) Services Market Scope

Report CoverageDetails
Growth Rate from 2024 to 2033CAGR of 14.05%
Global Market Size in 2023USD 1.24 Billion
Global Market Size in 2024USD 1.42 Billion
Global Market Size by 2033USD 4.63 Billion
Largest MarketNorth America
Base Year2023
Forecast Period2024 to 2033
Segments CoveredBy Service, By Service Provider, and By End user
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Health Economics and Outcomes Research (HEOR) Services Market Dynamics

Drivers

Key drivers of the HEOR services market include the expanding pharmaceutical and biotechnology sectors, which require comprehensive HEOR data to support drug development and commercialization. Increasing adoption of innovative healthcare technologies and personalized medicine further stimulates demand for HEOR services to demonstrate value and cost-effectiveness. Moreover, collaborations between academia, industry, and regulatory bodies are enhancing the sophistication and relevance of HEOR studies, driving market expansion.

Opportunities

The HEOR services market presents significant opportunities for providers to offer tailored solutions addressing specific market needs. There is a growing demand for real-world evidence studies leveraging big data analytics and patient registries to inform healthcare decision-making. Expanding into emerging markets and diversifying service portfolios to include specialized HEOR offerings for rare diseases and orphan drugs can unlock new growth avenues. Furthermore, addressing the increasing need for value communication and market access strategies presents strategic opportunities for HEOR service providers.

Challenges

Challenges faced by the HEOR services market include methodological complexities in conducting robust economic evaluations and outcomes research. Quality and consistency of real-world data pose challenges in generating reliable evidence for decision-making. Moreover, navigating the evolving regulatory landscape and adapting to changing healthcare policies across different regions require continuous innovation and expertise. Competition from in-house HEOR capabilities within pharmaceutical companies also presents a challenge for standalone HEOR service providers.

Read Also: Go Kart Market Size to Worth USD 211.88 Billion by 2033

Health Economics and Outcomes Research (HEOR) Services Market Recent Developments:

  • In May 2022, Trinity Life Sciences launched a project to explore the implications of significant developments and growth in Health Economics and Outcomes Research  (HEOR) in the United States.
  • In May 2022, Cigna, an American multinational managed health and insurance company, launched a new oncology consultation service to improve health outcomes for members.
  • In April 2022, Snowflake Inc., a cloud computing data storage company, launched healthcare and life sciences cloud consulting services that enable organizations to centralize, integrate, and exchange essential and sensitive data securely at scale.
  • In January 2024, the Professional Society for Health Economics and Outcomes Research announced the expansion of its editorial scope and its plan to transition to a gold open access journal.

Health Economics and Outcomes Research (HEOR) Services Market Companies

  • Cardinal Health
  • Axtria
  • McKesson Corp.
  • MEDLIOR
  • IQVIA
  • PharmaLex GmbH
  • ICON plc.
  • PPD Inc.
  • RTI Health Solutions
  • Syneos Health

Segments Covered in the Report

By Service

  • Economic evaluation
  • Real world data analysis and information
  • Clinical outcome
  • Market access solution and reimbursement
  • Others

By Service Provider 

  • Contract Research Organizations (CROs)
  • Consultancy

By End user

  • Government Organizations
  • Healthcare Providers
  • Health Care Payers
  • Pharma and Biotech Companies
  • Others

By Geography

  •  North America
  •  Europe
  •  Asia Pacific
  •  Latin America
  •  Middle East and Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/